Patients most likely to benefit from PANXEON screening include individuals with inherited genetic risk, a family history of pancreatic cancer, pancreatic cysts, or chronic pancreatitis.

Overview Debates Related claims Topics Sources

Childhood trauma leads people to develop psychosis

Geraldine Levano reached more than three years of cancer remission following her stage 3 colorectal cancer treatments.

Radon is the second leading cause of lung cancer after smoking, causing an estimated 21,000 deaths annually

Mass General Brigham Cancer Institute will offer services across eight cancer specialties, including gastrointestinal and thoracic oncology, by November 2026, MGB said

Machine-learning models integrating early antibody signatures discriminated individuals who would later develop Crohn's disease or ulcerative colitis from healthy controls up to 10 years before diagnosis, with AUC values of 0.90 and 0.84, respectively.

Study co-author Dr. You Zhou stated that combining gut bacteria and digestive chemicals distinguished individuals with mild cognitive impairment from healthy people with high accuracy.

Researchers from Cardiff University and Imperial College London found that older adults with mild cognitive impairment displayed significantly elevated levels of Izemoplasmatales spp. bacteria and the chemical proline in fecal samples.

The study utilized machine learning algorithms to analyze fecal sample biomarkers to diagnose mild cognitive impairment and predict condition progression speed.

Researchers profiled antibody responses against approximately 357,000 antigens across 2,000 serum samples, identifying 123,980 unique antibodies and finding significantly lower antibody diversity in individuals who later developed Crohn's disease or ulcerative colitis.

More young people need to get their brain scanned

In the Sungkyunkwan University cohort, each 1-unit increase in biological age acceleration based on nine routine blood markers was associated with a 7% higher risk of early-onset colorectal adenocarcinoma.

The original version of Freenome's blood-based SimpleScreen CRC screening test is already FDA-approved for colorectal cancer surveillance.

Dr. Aasma Shaukat stated at the ACG Annual Scientific Meeting that researchers plan to develop future iterations beyond version two of SimpleScreen CRC to further increase sensitivity for advanced lesions.

Dr. Aasma Shaukat and her research team plan to submit the updated SimpleScreen CRC test to the FDA for regulatory approval.

A study found advanced stage at diagnosis accounted for 24.9% of excess rural breast cancer deaths, while radiation omission and chemotherapy omission accounted for 11.4% and 7.9% respectively.

The American College of Obstetricians and Gynecologists guidelines recommend systemic hormone replacement therapy with estrogen and progestogen for women with a uterus to mitigate endometrial cancer risk from estrogen-stimulated uterine lining growth, or estrogen alone without

Satralizumab is a humanized monoclonal antibody designed to bind to soluble and membrane-bound interleukin-6 receptors, inhibiting interleukin-6-mediated inflammatory signaling

Thyroid eye disease is an inflammatory autoimmune condition affecting an estimated 16 women and 3 men per 100,000 population, commonly occurring in people with hyperthyroidism

Satralizumab is the first and only at-home subcutaneous treatment cleared by the FDA for adults with thyroid eye disease

Prior to satralizumab's approval, the FDA approved two intravenous thyroid eye disease treatments targeting the insulin-like growth factor 1 receptor: teprotumumab in 2020 and veligrotug in June 2026